Chronicle Journal: Finance

Short Sellers Back Off From Biotech ETFs

The Covid-19 brought certain sectors serendipitous gains like technology, but even that space is now seeing sell-offs amid a September sell-off. As such, short sellers are coming in to reap the rewards, but one area that they’re backing off from is biotechnology. “As market turbulence...
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.